| 1 |
Mok CC, Ho LY, Tse SM, et al. Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus [J]. Ann Rheum Dis, 2017, 76(8): 1420-1425.
|
| 2 |
费允云, 甘凤英, 侯勇, 等. 近25年系统性红斑狼疮的死因构成回顾性研究 [J]. 中华风湿病学杂志, 2012, 16(9): 596-600.
|
| 3 |
Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia: clinical implications and prognostic significance [J]. Ann Rheum Dis, 2005, 64(9): 1366-1369.
|
| 4 |
Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis [J]. Platelets, 2010, 21(5): 380-385.
|
| 5 |
Näslund TI, Gehrmann U, Qazi KR, et al. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity [J]. J Immunol, 2013, 190(6): 2712-2719.
|
| 6 |
Salvi V, Gianello V, Busatto S, et al. Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 [J]. JCI Insight, 2018, 3(10): e98204.
|
| 7 |
Tan L, Wu H, Liu Y, et al. Recent advances of exosomes in immune modulation and autoimmune diseases [J]. Autoimmunity, 2016, 49(6): 357-365.
|
| 8 |
Cosenza S, Toupet K, Maumus M, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis [J]. Theranostics, 2018, 8(5): 1399-1410.
|
| 9 |
Rozo C, Chinenov Y, Maharaj RK, et al. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE [J]. Ann Rheum Dis, 2017, 76(4): 740-747.
|
| 10 |
Shenkar R, Peiper A, Pardo H, et al. Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease [J]. Stroke, 2019, 50(3): 738-744.
|
| 11 |
Liu P, Xiao Z, Yan H, et al. Baicalin suppresses Th1 and Th17 responses and promotes Treg response to ameliorate sepsis-associated pancreatic injury via the RhoA-ROCK pathway [J]. Int Immunopharmacol, 2020, 86: 106685.
|
| 12 |
Schillaci O, Fontana S, Monteleone F, et al. Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity [J]. Sci Rep, 2017, 7(1): 4711.
|
| 13 |
Zhang C, Guo F, Chang M, et al. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-κB signaling axis and glycocalyx enhancement [J]. Exp Cell Res, 2019, 384(1): 111596.
|
| 14 |
Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997, 40(9): 1725.
|
| 15 |
George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura [J]. N Engl J Med, 1994, 331(18): 1207-1211.
|
| 16 |
Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia: clinical implications and prognostic significance [J]. Ann Rheum Dis, 2005, 64: 1366-1369.
|
| 17 |
Friedmann AM, Sengul H, Lehmann H, et al. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A revaluation of prophylactic platelet transfusions [J]. Transfus Med Rev, 2002, 16(1): 34-45.
|
| 18 |
Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE [J]. Arthritis Rheum, 1992, 35(6): 630-640.
|
| 19 |
Perez-Hernandez J, Redon J, Cortes R. Extracellular vesicles as therapeutic agents in systemic lupus erythematosus [J]. Int J Mol Sci, 2017, 18(4): 717.
|
| 20 |
Zhao Y, Wei W, Liu ML. Extracellular vesicles and lupus nephritis - new insights into pathophysiology and clinical implications [J]. J Autoimmun, 2020, 115: 102540.
|
| 21 |
Huang B, Krafft PR, Ma Q, et al. Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice [J]. Neurobiol Dis, 2012, 46(1): 204-214.
|
| 22 |
Shi Y, Zhang L, Pu H, et al. Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury [J]. Nat Commun, 2016, 27(7): 10523.
|
| 23 |
Lee JY, Park JK, Lee EY, et al. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response [J]. Arthritis Res Ther, 2016, 18(1): 264.
|
| 24 |
Sun Y, Liu XL, Zhang D, et al. Platelet-derived exosomes affect the proliferation and migration of human umbilical vein endothelial cells via miR-126 [J]. Curr Vasc Pharmacol, 2019, 17(4): 379-387.
|
| 25 |
Sun L, Zhang W, Li Z, et al. The expression of cerebrospinal fluid exosomal miR-630 plays an important role in the dysfunction of endothelial cells after subarachnoid hemorrhage [J]. Sci Rep, 2019, 9(1): 11510.
|
| 26 |
Duan S, Wang F, Cao J, et al. Exosomes derived from microRNA-146a-5p-enriched bone marrow mesenchymal stem cells alleviate intracerebral hemorrhage by inhibiting neuronal apoptosis and microglial M1 polarization [J]. Drug Des Devel Ther, 2020, 14: 3143-3158.
|